BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CREST - ECPv5.1.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CREST
X-ORIGINAL-URL:https://crest.science
X-WR-CALDESC:Events for CREST
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20210505T121500
DTEND;TZID=Europe/Helsinki:20210505T133000
DTSTAMP:20260712T061943
CREATED:20210429T082009Z
LAST-MODIFIED:20210429T082009Z
UID:12641-1620216900-1620221400@crest.science
SUMMARY:Pierre DUBOIS (TSE)   - "Bargaining and International Reference Pricing in the Pharmaceutical Industry"
DESCRIPTION:Microeconomics Seminar : \nTime: 12:15 pm – 1:30pm\nDate:  5th Mai 2021\nRoom: VISIO \n\nPierre DUBOIS (TSE) – “Bargaining and International Reference Pricing in the Pharmaceutical Industry” \nAbstract: The United States spends twice as much per person on pharmaceuticals as European countries\, in large part because prices are higher in the US. This fact has led policymakers in the US to consider legislation for price controls. This paper assesses the effects of a hypothetical US reference pricing policy that would cap prices in US markets by those offered in Canada. We estimate a structural model of demand and supply for pharmaceuticals in the US and Canada\, in which Canadian prices are set through a negotiation process between pharmaceutical companies and the Canadian government. We then simulate the impacts of the counterfactual international reference pricing rule\, allowing firms to internalize the cross-country impacts of their prices both when setting prices in the US and when negotiating prices in Canada. We find that such a policy results in a slight decrease in US prices and a substantial increase in Canadian prices. The magnitude of these effects depends on the particular structure of the policy. Overall\, we find modest consumer welfare gains in the US but substantial consumer welfare losses in Canada. Moreover\, we find that pharmaceutical profits increase in net\, suggesting that reference pricing of this form would constitute a net transfer from consumers to firms.. Joint with Ashvin Gandhi and Shoshana Vasserman. \n\n  \n\nOrganizers:\nRoxana Fernandez Machado (CREST)\, Julien Combe (CREST)\, and Matias Nunez (CREST)\nSponsors:\nCREST\n\n  \n
URL:https://crest.science/event/pierre-dubois-tse-bargaining-and-international-reference-pricing-in-the-pharmaceutical-industry/
CATEGORIES:Microeconomics
END:VEVENT
END:VCALENDAR